Opmedic (TSE: OMG) had its price target decreased by LB Securities from C$3.00 to C$2.70 in a research note issued to investors on Monday, Stock Ratings Network.com reports. The firm currently has a hold rating on the stock.
Separately, analysts at Laurentian cut their price target on shares of Opmedic from C$3.00 to C$2.70 in a research note to investors on Monday. They now have a hold rating on the stock.
Shares of Opmedic (TSE: OMG) remained flat at $2.28 during during mid-day trading trading on Monday. Opmedic has a 52 week low of $2.13 and a 52 week high of $3.21. The stock’s 50-day moving average is currently $2.3. The company has a market cap of $37.9 million and a P/E ratio of 14.25.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, July 31st. Investors of record on Wednesday, July 24th will be paid a dividend of $0.02 per share. This represents a $0.08 annualized dividend and a dividend yield of 3.54%.
OPMEDIC Group Inc is a Canada-based healthcare-related company that provides a range of professional fertility services, as well as laboratory and genetic services, sperm banking services, and surgical and endoscopic services and facilities for patients and surgeons.